Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients

Transplantation. 2005 Mar 27;79(6):742. doi: 10.1097/01.tp.0000146845.93929.ec.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Antilymphocyte Serum / immunology*
  • Antilymphocyte Serum / therapeutic use
  • Disease Susceptibility
  • Female
  • Graft Rejection / immunology*
  • Graft Rejection / therapy*
  • Humans
  • Immunoglobulins, Intravenous / immunology*
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunotherapy*
  • Kidney Transplantation / immunology*
  • Male
  • Transplantation

Substances

  • Antilymphocyte Serum
  • Immunoglobulins, Intravenous